
Home / Clinics Supported / Hormone Optimization / Men's Health & TRT
TRT generates over 246,000 U.S. searches per month. In most markets the nearest provider is a telehealth app, no local clinic building the in-person relationship that creates long-term patient loyalty. ACG builds that clinic. No medical background is required to own the business; an independent, state-licensed Medical Director directs all clinical care.
Book a Strategy CallTestosterone replacement therapy generates over 246,000 U.S. searches per month, more than any other single men's health treatment category. The demand is not speculative. It is documented, consistent, and growing.
The men's health patient is motivated, research-literate, and willing to pay for a provider who communicates clearly and delivers results. The local clinic that earns his trust in January still has him, and his referrals, in December.
In most U.S. markets, the nearest TRT provider is a telehealth company. No in-office labs. No consistent provider relationship. No physical presence building trust in the community. The entrepreneur who opens the local alternative captures what telehealth cannot.
The TRT patient who gets labs monitored quarterly, adjusts his protocol with a provider who knows his baseline, and sees real results, stays enrolled for years. That is the highest lifetime value relationship in cash-pay men's health.
Representative of broader category trends. Local demand varies by market.
The core protocol stack, built around testosterone optimization and the natural adjacencies that increase patient lifetime value.
Injectable, pellet, and topical TRT protocols prescribed and monitored by your Medical Director. The primary revenue driver and the reason patients walk in.
Baseline and ongoing labs, comprehensive metabolic panel, CBC, hormone panel, that create the ongoing relationship and justify protocol continuity.
Sermorelin, prescriber-directed, paired with TRT for growth hormone support in men over 40, and PT-141 as an FDA-approved option for sexual wellness adjacency. CJC-1295 and ipamorelin are the two patients ask for by name, and neither is on the 503A Bulks List. See our Peptide Therapy page for the full compound status table.
Shockwave therapy, PRP, and ED protocol options that expand the men's health service menu without requiring a separate clinic entity.
Metabolic panel, body composition tracking, and FDA-approved GLP-1 adjacency for the TRT patient who needs comprehensive metabolic support, see our Metabolic Weight Loss page for the full model. The TRT patient who adds metabolic support stays enrolled longer and refers more actively.
Monthly protocol and lab monitoring memberships that create predictable recurring revenue and keep patients engaged through the full protocol cycle.
Testosterone is a Schedule III controlled substance. DEA registration, prescribing structure, and record-keeping obligations are specific requirements that vary by state and must be sequenced correctly before the first patient is seen.
Compounding pharmacy relationships for testosterone require vetting. The Medical Director oversight agreement for a TRT practice has specific requirements. ACG has navigated this across hundreds of launches. The framework is built. The MD network spans all 50 states. The pharmacy relationships are pre-vetted.
Testosterone is Schedule III. ACG sequences the registration requirements, prescribing structure, and record-keeping obligations correctly for your state.
Vetted MDs across all 50 states who understand TRT clinic oversight requirements. ACG coordinates the supervision agreement.
Pre-vetted compounding pharmacy partners for testosterone and lawfully compoundable adjunct compounds at preferred pricing.
Patient intake, informed consent frameworks, and clinical protocols established before your first patient.
TRT advertising has specific platform restrictions. ACG builds campaigns that attract the right patients without compliance exposure.
Operators looking at men's health and TRT want straight answers on prescriber requirements, controlled substance handling, telehealth rules, and how pricing and lab cadence actually work. Honest answers below.
If something isn't covered here, that's what the consultation is for. No pressure, no pitch.
View All FAQsBook a free 30-minute strategy call. ACG will walk you through the men's health opportunity in your market, the compliance picture, the supplier access, and what the process looks like from first conversation to open doors.
Book a Strategy CallFree 30-minute call · No pitch · ACG works with a select number of clients at any given time
Regenerative health is one of the most heavily scrutinized spaces in medicine. Knowing the rules is not a footnote to what we do. It is the foundation. Here is how we structure every clinic we help launch.
You own and operate the business. Every clinical, prescribing, and treatment decision is made by an independent, state-licensed Medical Director, structured to respect Corporate Practice of Medicine laws in your state. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications, and cellular products each carry their own federal and state rules, and not every product or use is FDA-approved. Some, like exosomes for therapeutic use, are not FDA-approved at all, and we steer you away from them. We help you build a treatment menu on defensible, compliant options and a marketing approach that holds up to FDA, FTC, and state medical board scrutiny.
We show you real ranges, not fantasy numbers, and we never promise an income or a clinical outcome. What you earn depends on your market, your capital, and your execution. We would rather set honest expectations than sell you a dream.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe, or sell any drug, biologic, device, or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the regulatory compliance of every product, therapy, and claim. See our full regulatory notice below.